Serum Procalcitonin, Use of Antibiotics, and Patient Outcome

Abstract

Objective: To evaluate the impact of serum procalcitonin (PCT) testing on use of antibiotics and patient outcome. Design: A retrospective chart review evaluation of the patients who had a serum procalcitonin test performed at one medical center. Setting: One academic medical center, Mount Sinai Medical Center, Miami Beach. Participants: One hundred and forty four consecutive patients who had procalcitonin determined beginning in January 2014. Measurements: We analyzed patient age, mortality, length of stay in intensive care unit and total hospital stay, presence of positive blood culture, and if on antibiotics at forty- eight and one hundred and twenty hours after PCT determination. Results: There were seventy two patients with a positive PCT determination (>0.5 ng/ml) and seventy two patients with negative PCT (<0.5 ng/ml). Patients with a positive serum PCT had a longer hospital length of stay, longer length of stay in Intensive Care Unit (ICU), were more likely to have a positive blood culture, more likely to be on antibiotics at 120 hours after PCT, and had higher mortality, (p<.05). Conclusion: Serum PCT level appears to predict severity of illness, mortality, and continued use of antibiotics. Negative PCT did not predict stopping of antibiotic treatment at forty-eight hours after the test.

Authors and Affiliations

Robert C Goldszer, MD, MBA, Alexandra Franco, MD, Bryan Tolentino, MD, Denise Diaz, MD, Pooja Pundhir, MD,Diana Morlote, MD, Nancimae Miller, PhD, Lydia Howard, MD Cynthia Rivera MD, Claudio Tuda MD, Kenneth Ratzan MD, Larissa Cabarga, MD, Luigi Cubbedu, MD

Keywords

Related Articles

Evaluation of Toxic Potentiality of Carbon Black on Respiratory Tract of Rats

Introduction: Particle pollution is a threat to human health, especially Nanoparticle pollution is threatening. In the present study we are studying the toxicity of CARBON BLACK to assess their potential in damaging huma...

Prevalence and Pattern of Self-Medication among Undergraduate Medical Students

Background: Self-medication is becoming a Universal entity wherein, drugs are given over-the-counter without prescription, providing a low cost alternative for people, irrespective of rural-urban differences[1], which mi...

Quality Of Life of Multi Drug Resistant Tuberculosis Cases of Kashmir Valley

Background: Tuberculosis is a chronic disease; with serious repercussions on not only physical health buton overall well-being of an individual. Methods: A total of 66 cases were interviewed (33 Multi drug resistant tube...

Frequency of Heart Diseases in Patients with Different Personality Types

Introduction: Heart disease as a leading cause of morbidity and mortality is of global concern. 17 million people die of Cardiovascular Diseases (CVD) each year. An impatient and over ambitious personality can develop he...

A Sporadic Case of Darier Disease with Acrokeratosis Verruciformis like Lesions: Treated Effectively with Oral and Topical Retinoid

Darier disease (DD) is a type of autosomal dominant genodermatosis with calcium pump defect. We are reporting a case of Darier disease because of its rarity. A 24 year old man presented with multiple pruritic dark warty...

Download PDF file
  • EP ID EP181297
  • DOI -
  • Views 55
  • Downloads 0

How To Cite

Robert C Goldszer, MD, MBA, Alexandra Franco, MD, Bryan Tolentino, MD, Denise Diaz, MD, Pooja Pundhir, MD, Diana Morlote, MD, Nancimae Miller, PhD, Lydia Howard, MD Cynthia Rivera MD, Claudio Tuda MD, Kenneth Ratzan MD, Larissa Cabarga, MD, Luigi Cubbedu, MD (2016). Serum Procalcitonin, Use of Antibiotics, and Patient Outcome. International Journal of Innovative Research in Medical Science, 1(7), 324-327. https://europub.co.uk/articles/-A-181297